Biblio
.
Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.
. Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression. Int J Pharm. 2020:119236.
Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol. 2020:173235.
Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
Silencing of p68 and STAT3 synergistically diminishes cancer progression. Life Sci. 2020:117499.
Blockage of immune checkpoint molecules increases T cell priming potential of dendritic cell vaccine. Immunology. 2019.
Hypoxia inducible factors in the tumor microenvironment as therapeutic targets of cancer stem cells. Life Sci. 2019:116952.
. Regulatory T cells in breast cancer as a potent anti-cancer therapeutic target. Int Immunopharmacol. 2019;78:106087.
.